Considering the improvements of CRP and lactic acid, it is reasonable to interpret that continuous infusion is advantageous for resolving infection by obtaining an appropriate concentration of antibiotics for sepsis patients with pharmacokinetic variations [25,26,27,28]. The gene discussed is CRP; the disease is Sepsis.